WHAT YOU NEED TO KNOW
  • Researchers compared 20 antidepressants using 115 previous clinical trials involving more than 30,000 people.
  • Escitalopram, duloxetine and agomelatine performed better over time than fluoxetine, the study’s main comparison drug.
  • Experts emphasized that medication benefits and side effects differ among patients, making individualized treatment decisions essential.
  • The findings cannot predict which antidepressant will work best for a specific person, and patients should consult doctors before changing medication.

Three antidepressants may outperform fluoxetine in helping people with depression improve and remain well over time, according to a large new study. The findings placed escitalopram, duloxetine and agomelatine ahead of fluoxetine, a widely used medicine commonly known by the brand name Prozac.

Published in The Lancet Psychiatry, the research compared 20 antidepressants. Investigators examined how effectively the medications eased symptoms of depression and helped prevent those symptoms from returning over time.

Researchers analyzed 115 previous clinical trials involving more than 30,000 people, according to a news release from Radboud University Medical Center in the Netherlands. Rather than recruiting and following a new group of patients, they combined results from those earlier trials.

Fluoxetine served as the main comparison drug in the analysis. Escitalopram, which is sold under the brand name Lexapro, duloxetine, sold as Cymbalta, and agomelatine delivered better long term results than fluoxetine.

Eli Lilly told Fox News Digital that the company stopped manufacturing Prozac in 2024. It added that fluoxetine remains available through many generic medicines approved by the FDA and said neither the study nor the university news release specifically mentioned Prozac or any Lilly product.

The results suggest antidepressants can continue helping patients after their symptoms have improved. However, the analysis also indicated that some of the medications performed better than others when researchers examined whether patients remained well over time.

Paul van Haaren, a researcher at Radboud University Medical Center who worked on the study, said the three leading medications do not offer identical advantages. Each carries different benefits and drawbacks that can affect treatment decisions.

“Escitalopram is already widely used,” van Haaren said in the release. “Agomelatine works well, but one of its side effects is the risk of liver failure. Duloxetine is less well-known and is prescribed less frequently as a first-line treatment.”

Do you read nutrition labels before buying packaged foods?

By completing the poll, you agree to receive emails from Being Healthy News, occasional offers from our partners and that you've read and agree to our privacy policy and legal statement.

Among the selective serotonin reuptake inhibitors included in the research, escitalopram appeared to perform best at helping patients remain well over time. Still, researchers did not present the result as evidence that every person with depression should receive escitalopram.

Eric Ruhé, a professor of difficult-to-treat depression at Radboud University Medical Center, said the study could eventually affect how doctors select antidepressants. He emphasized that prescribing decisions require consideration of benefits and unwanted effects for each patient.

“As a prescriber, you consider the balance between a medication's benefits and side effects,” Ruhé said in the release. “That balance differs from person to person.”

Dr. Carole Lieberman, a board certified psychiatrist based in Beverly Hills, California, who did not participate in the research, urged caution in interpreting the results. She also noted that agomelatine is not approved in the United States.

“The best way to treat someone with depression is not always with antidepressants, and certainly not with antidepressants alone,” Lieberman told Fox News Digital. She said psychotherapy, also known as talk therapy, can play an important role, while some patients may benefit from combining medication with therapy.

The study had limitations acknowledged by the researchers. Its findings came from pooling 115 previous clinical trials rather than enrolling a new patient group and tracking those participants over a designated period.

The results also cannot predict which antidepressant will work best for a particular individual. Researchers stressed that patients and doctors should weigh potential benefits against side effects, and the release advised people with questions to speak with their doctor before changing any antidepressant medication.


Are you feeling overwhelmed or hopeless right now? Have you been withdrawing from people or activities you usually enjoy? Are you having thoughts about hurting yourself, or feeling like things will never improve?

You do not have to handle those feelings alone. Support is available, and talking to someone can make a difference. You can reach out to the 988 Suicide & Crisis Lifeline by calling or texting 988, or by chatting online at 988lifeline.org. Trained counselors are available 24 hours a day to listen and help.

If you believe someone is in immediate danger, call emergency services right away. Even a small step, like reaching out to a trusted friend, family member, or professional, can help create a path forward.